Cholesgen Co. Ltd., a biotech/biomedical research company, entered into a collaboration with AstraZeneca, to advance research and development in hypercholesterolemia and related metabolic diseases. The three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets from Cholesgen’s early-stage portfolios. Cholesgen will be entitled to...